HomeVSTM • NASDAQ
add
Verastem Inc
Previous close
$7.93
Day range
$7.49 - $8.02
Year range
$2.10 - $12.44
Market cap
417.06M USD
Avg Volume
1.44M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 44.17M | 57.43% |
Net income | -52.10M | -53.86% |
Net profit margin | — | — |
Earnings per share | -0.79 | 19.39% |
EBITDA | -44.16M | -57.43% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 117.57M | 6.76% |
Total assets | 131.70M | 6.60% |
Total liabilities | 164.13M | 112.28% |
Total equity | -32.43M | — |
Shares outstanding | 54.95M | — |
Price to book | -12.59 | — |
Return on assets | -94.70% | — |
Return on capital | -382.64% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -52.10M | -53.86% |
Cash from operations | -38.68M | -36.63% |
Cash from investing | — | — |
Cash from financing | 67.43M | 7,870.09% |
Net change in cash | 28.75M | 717.25% |
Free cash flow | -24.28M | -29.15% |
About
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
Founded
2010
Headquarters
Website
Employees
78
